Philips Collaborates with BioIntelliSense to Enhance Remote Patient Monitoring

 Philips Collaborates with BioIntelliSense to Enhance Remote Patient Monitoring

Philips Collaborates with BioIntelliSense to Enhance Remote Patient Monitoring

Shots:

  • Royal Philips collaborated with BioIntelliSense, to integrate its BioSticker medical device into Philips’ RPM offering to help monitor at-risk patients from the hospital into the home
  • Addition of multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms, including COVID-19
  • The BioSticker is a single-use, FDA-cleared 510k class II wearable medical device that enables at-home passive monitoring with minute level data across a broad set of vital signs, physiological biometrics and symptomatic events (skin temperature, resting heart rate, resting respiratory rate, body position, activity levels, cough frequency) on a single device 30days

Click here to read full press release/ article | Ref: Philips | Image: Philips

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post